Vingraf 0.5mg Capsule 10'S
Key Information
Generic Name
Generic Name Tacrolimus 0.5 mg
Manufacturer
Emcure Pharmaceuticals Ltd
Variant
10 Capsule(s) in a Strip
Country of Origin
India
Detailed Information
Introduction
INTRODUCTION ABOUT VINGRAF 0.5MG CAPSULEVINGRAF 0.5MG CAPSULE contains Tacrolimus which belongs to the group of medicines called Immunosuppressants. It is used to manage graft rejection in patients undergoing organ transplantation. It can also be used to manage an ongoing graft rejection of the newly transplanted organ. It is mostly used in combination with other immune suppressants to achieve maximum benefits. Tacrolimus suppresses your body’s immune functions and enables your body to accept the transplanted organ. Take VINGRAF 0.5MG CAPSULE regularly as instructed by your doctor. While undergoing therapy with VINGRAF 0.5MG CAPSULE your doctor will periodically monitor your heart functions and nerve functions to avoid the risk of
Uses
OF VINGRAF 0.5MG CAPSULE Prevents graft rejection following organ transplantation
How It Works
VINGRAF 0.5MG CAPSULE is an immunosuppressive agent. It works by blocking the release of certain chemicals in the body (such as T-cells) that triggers the immune response. It suppresses your body’s immune functions and enables your body to accept the transplanted organ. As a result, it manages the risk of graft rejection and increases the survival of the newly transplanted organ.
Directions for Use
Take VINGRAF 0.5MG CAPSULE 1 hour before meals or 2-3 hours after meals or as directed by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of therapy for you depending on your age, body weight and disease condition. Do not stop taking VINGRAF 0.5MG CAPSULE without consulting your doctor.
Side Effects
side effects. Do not take VINGRAF 0.5MG CAPSULE without consulting your doctor if you are pregnant or breastfeeding. Both men and women taking VINGRAF 0.5MG CAPSULE must use a suitable contraceptive method (such as condoms or oral contraceptive pills) to avoid pregnancy while undergoing therapy with VINGRAF 0.5MG CAPSULE. The most common side effects of taking VINGRAF 0.5MG CAPSULE are an increase in blood sugar levels, increased blood cholesterol levels, difficulty in falling asleep, increased blood potassium levels, high blood pressure, headache, dizziness, indigestion, oedema and increased infections. Consult your doctor if any of these side effects worsen. USES OF VINGRAF 0.5MG CAPSULE Prevents graft rejection following organ transplantation HOW VINGRAF 0.5MG CAPSULE WORKSVINGRAF 0.5MG CAPSULE is an immunosuppressive agent. It works by blocking the release of certain chemicals in the body (such as T-cells) that triggers the immune response. It suppresses your body’s immune functions and enables your body to accept the transplanted organ. As a result, it manages the risk of graft rejection and increases the survival of the newly transplanted organ. DIRECTIONS FOR USETake VINGRAF 0.5MG CAPSULE 1 hour before meals or 2-3 hours after meals or as directed by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of therapy for you depending on your age, body weight and disease condition. Do not stop taking VINGRAF 0.5MG CAPSULE without consulting your doctor. SIDE EFFECTS OF VINGRAF 0.5MG CAPSULECOMMON increased blood sugar levels (diabetes) increased blood pressure increased potassium levels in the blood difficulty in falling asleep feeling shaky or trembling headache, dizziness liver problems, kidney problems nausea, vomiting stomach pain, diarrhea, constipation, bloating mouth ulcers low RBC and platelet count oedema (swelling of body parts) increased blood cholesterol levels feeling anxious, confused, disoriented or depressed fits, tingling and numbness of hands and feet eye sensitivity towards light, ringing sound in the ears abnormal or faster heartbeat skin rash and itching, acne, hair loss increased sweating pain in joints, limbs, back and feet, muscle spasms weight gain increased acidity in the blood RAREStop taking VINGRAF 0.5MG CAPSULE and contact your doctor immediately if you experience any of the following side effects such as: severe stomach pain with or without fever, chills, nausea and vomiting signs of skin cancer (such as growth or lump on the skin, dark patches on the skin, flesh-coloured or scar-like lesions, scaly patches on sun-exposed areas) signs of lymph cancer (enlarged lymph nodes with tiredness, fever, night sweats, itchy skin, weight loss) increased frequency of opportunistic infections (including skin infections, urinary tract infections, respiratory tract infections, stomach infections, oral infections, etc.) flu-like symptoms (such as fever, sore throat, cold, cough, feeling unwell) signs of brain infection (such as memory loss, difficulty in thinking, trouble in walking or vision loss) signs of kidney damage such as Haemolytic uraemic syndrome causing low urine output, extreme tiredness, yellowing of the skin or eyes and abnormal bruising or bleeding with signs of infection blurred vision, changes in colour of the vision or vision loss signs of allergic reactions (such as severe skin rash with itching, blistering and peeling of the skin, mouth, eyes, throat, genitals, swelling of the face and tongue, bleeding under the skin causing the appearance of red-pin point dots on the skin, skin swelling, along with fever, tiredness, confusion or jaundice) signs of heart problems (such as chest pain, vertigo, fainting, nausea, palpitations and difficulty in breathing)
Warnings & Precautions
& PRECAUTIONSPREGNANCYVINGRAF 0.5MG CAPSULE should be used in pregnant women only if it is considered necessary by the physician. Therefore, inform your doctor before taking it. Women of childbearing potential must use a suitable contraceptive method to avoid pregnancy while undergoing therapy with VINGRAF 0.5MG CAPSULE. BREASTFEEDINGVINGRAF 0.5MG CAPSULE may pass through breast milk. Therefore, it is not recommended for use in breastfeeding woman. However, consult your doctor before taking it. DRIVING AND USING MACHINESDo not drive or operate any heavy tools or machines if you experience dizziness or sleepiness after taking VINGRAF 0.5MG CAPSULE. ALCOHOLAvoid consumption of alcohol while taking VINGRAF 0.5MG CAPSULE as it might make you feel dizzier or sleepy. KIDNEYVINGRAF 0.5MG CAPSULE should be used with caution in patients with kidney problems. Therefore, consult your doctor before taking it. LIVERVINGRAF 0.5MG CAPSULE should be used with caution in patients with liver problems. Therefore, consult your doctor before taking it. ALLERGYTalk to your doctor before taking VINGRAF 0.5MG CAPSULE if you are allergic to Tacrolimus or to any macrolide antibiotics (such as erythromycin, azithromycin). HEART DISEASEVINGRAF 0.5MG CAPSULE should be used with caution in patients with heart problems (such as prolonged QT interval). Therefore, consult your doctor before taking it. OTHERSBefore taking VINGRAF 0.5MG CAPSULE inform your doctor if you: are scheduled for any vaccination in the upcoming days high blood cholesterol levels have high blood potassium levels Use in pediatrics: The safety and effectiveness of VINGRAF 0.5MG CAPSULE have not been established in children and adolescents (aged below 18 years) undergoing transplantation. Therefore, consult your doctor before taking it. Use in geriatrics: VINGRAF 0.5MG CAPSULE should be used with caution in elderly patients. Therefore, consult your doctor before taking it.
Drug Interactions
SA. Drug-Drug interactions: Before taking VINGRAF 0.5MG CAPSULE inform your doctor if you are taking the following medicines such as: St. John’s Wart (an herbal medicine used to manage depression) vaccinations cyclosporin, mycophenolic acid (other medicines used to suppress immune functions) medicines used to manage fungal infections (Ex. ketoconazole, fluconazole, clotrimazole, amphotericin B) macrolide antibiotics (Ex. erythromycin, clarithromycin, azithromycin, flucloxacillin) medicines used to manage tuberculosis (Ex. isoniazid, rifampicin) medicines used to manage HIV infections (Ex. acyclovir, ritonavir, nelfinavir, saquinavir, efavirenz, etravirine, nevirapine) Letemovir (a medicine used to manage human cytomegalovirus) medicines to manage fever and pain (Ex. metamizole, ibuprofen) medicines used to manage cancer (Ex. imatinib, crizotinib, nilotinib) medicines used to manage hepatitis C infection (Ex. telaprevir, boceprevir, the combination ombitasvir/paritaprevir/ritonavir with or without dasabuvir, elbasvir/grazoprevir and glecaprevir/pibrentasvir) medicines used to manage gastric problems (Ex. omeprazole, cimetidine, magnesium hydroxide, aluminum hydroxide) medicines used to manage nausea and vomiting (Ex. metoclopramide) medicines that can increase blood potassium levels (such as potassium supplements or potassium-sparing diuretics (Ex. amiloride, triamterene or spironolactone)) trimethoprim or cotrimoxazole (used to manage bacterial infections) oral contraceptives (birth control pills) Ex. ethinylestradiol medicines used to manage heart problems (Ex. nifedipine, verapamil, diltiazem, amiodarone) medicines used to control blood cholesterol levels (Ex. atorvastatin, fluvastatin) medicines used to manage fits (Ex. carbamazepine, phenytoin, cannabidiol) corticosteroids (used to manage allergic or autoimmune diseases) Ex. prednisolone, methylprednisolone medicines used to manage depression (Ex. nefazodone) medicines used to manage diabetes (Ex. metformin, glimepiride) extracts of Schisandra sphenanthera (used to manage mental illness) anticoagulants (used for blood thinning) Ex. warfarin, heparin B. Drug-food interactions: VINGRAF 0.5MG CAPSULE may interact with food. To avoid this, take VINGRAF 0.5MG CAPSULE 1 hour before meals or 2-3 hours after meals. Avoid consuming grapes or grapefruit juice while taking VINGRAF 0.5MG CAPSULE as it may increase the risk of side effects. Overdosage: If you or anyone else accidentally took more VINGRAF 0.5MG CAPSULE, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose might include tremors, abnormal kidney function results in less or no urine output, increased blood pressure, leg swelling and lack of energy. SYNOPSIS Drug : Tacrolimus Pharmacological Category : Calcineurin Inhibitors Therapeutic Indication : Prevents graft rejection Dosage Forms : Capsules, Tablets, Ointment, Lotion, solution, Topical Solution, Oral gel, eye ointment MORE INFORMATION Keep VINGRAF 0.5MG CAPSULE out of reach of children Store VINGRAF 0.5MG CAPSULE at room temperature
Article Information
Written By
DETAILS Written By Srilekha. R
Medical Content Writer
Reviewed By
Dr. Sankara Babu Gorle
Medical Expert
Last Updated
27 Oct 2022